Development of a biobank in the structure of scientific and diagnostic and treatment institutions and prospects for interregional integration

The formation of biobanks in the structure of scientific and treatment and diagnostic institutions with prospects for interregional integration is a fundamental link in monitoring and predicting diseases of various origins, creating and testing highly effective diagnostics, and developing novel therapeutic agents.

Aim. To describe standard operating procedures and principles for the formation of bioresource collections (BRC) in medical institutions with biobanking.

Material and methods. The data of scientific and practical biomedical projects using BRC obtained from patients with genetic, multifactorial and infectious diseases in St. Petersburg and Surgut are presented. As of September 2022, the BRC collected on the basis of the Pediatric Research and Clinical Center for Infectious Diseases of the Federal Medical and Biological Agency includes biosamples from 1619 patients, and the BRC collected in the Medical Institute of Surgut State University includes biosamples from 450 patients and healthy individuals of different sex and age. The selection of biosamples from apparently healthy individuals and patients with various diseases can serve as a strategically important resource for future research in terms of etiology, epidemiology, the development of regulatory environment and scales, innovations in the development of diagnostic approaches and treatment of the Russian population.

1. Prinz F, Schlange T, Asadullah K. Believe it or not: how much can we relyon published data on potential drug targets? Nat Rev Drug Disc. 2011;10(9):712. doi:10.1038/nrd3439-c1.

2. Reznik ON, Kuzmin DO, Skvortsov AE, et al. Biobanks are an essential tool for transplantation. History, current state, perspectives. Russian Journal of Transplantology and Artificial Organs. 2016;18(4):123-32. (In Russ.) doi:10.15825/1995-1191-2016-4-123-132.

3. Hewitt R, Watson P. Defining biobank. Biopreserv Biobank. 2013;11:309-15. doi:10.1089/bio.2013.0042.

4. OECD. Creation and Governance of Human Genetic Re - search Databases. OECD Publishing, Paris. 2006. doi:10.1787/9789264028531-en.

5. Ilesanmi OS, Afolabi AA. Biobanking of COVID-19 specimens during the pandemic: The need for enhanced biosafety. Afr J Lab Med. 2021;10(1):1379. doi:10.4102/ajlm.v10i1.1379.

6. Moore HM, Kelly AB, Jewell SD, et al. Biospecimen reporting for improved study quality (BRISQ). Cancer Cytopathol. 2011;119:92- 101. J Proteome Res. 2011;10:3429-3438. Biopreserv Biobank. 2011;9:57-70. doi:10.1089/bio.2010.0036.

7. Sivakova OV, Pokrovskaya MS, Metelskaya VA, et al. International rules for description of biospecimens are an important factor in improving the quality of researches. Profilakticheskaya Meditsina. 2019;22(6):95-9. (In Russ.) doi:10.17116/profmed20192206295.

8. Anisimov SV, Meshkov AN, Glotov AS, et al. et al. National Association of Biobanks and Biobanking Specialists: New Community for Promoting Biobanking Ideas and Projects in Russia. Biopreserv Biobank. 2021;19:73-82. doi:10.1089/bio.2020.0049.

9. Illarionov RA, Kosyakova OV, Vashukova ES, et al. Collection of samples from women at different stages of pregnancy to search for early biomarkers of preterm birth. Cardiovascular Therapy and Prevention. 2020;19(6):2708. (In Russ.) doi:10.15829/1728-8800-2020-2708.

10. Liu Y, Gao H, Hu Y, et al. Quality Control System in an Obstetrics and Gynecology Disease Biobank. Biopreserv Biobank. 2019; 17(1):27-38. doi:10.1089/bio.2018.0056.

11. Kinkorová J. Education for future biobankers — The state-ofthe-art and outlook. EPMA. 2021;10;12(1):15-25. doi:10.1007/s13167-021-00234-5.